Dr. Doreen Matsui, MD, FRCPC
Children’s Health Research Institute
Scientist, Children’s Optimal Therapeutics Program
Lawson Health Research Institute
Associate Scientist, Children’s Health Research Institute
Children’s Hospital of Western Ontario
Consultant, Clinical Pharmacology
University of Western Ontario
Associate Professor, Departments of Paediatrics and Medicine
Contact Information
Tel: (519) 685-8500 Ext. 58268
Fax: (519) 685-8156
E-mail: Doreen.matsui@lhsc.on.ca
Brief Biography
Dr. Doreen Matsui received her Degree in Medicine from Queen’s University in 1985. She completed a residency in paediatrics at the Children’s Hospital of Eastern Ontario, University of Ottawa and a fellowship in paediatric clinical pharmacology at the Hospital for Sick Children, University of Toronto. She also received a Certificate in Clinical Epidemiology from The University of Western Ontario in 2002.
Dr. Matsui joined the Schulich School of Medicine at The University of Western Ontario in 1993, and is a paediatrician and clinical pharmacologist at the Children’s Hospital of Western Ontario. She is an Associate Professor in the Departments of Paediatrics and Medicine. She currently is a member of the Review Board for Health Sciences Research Involving Human Subjects at The University of Western Ontario and Chair of the Drug Therapy and Hazardous Substances Committee of the Canadian Paediatric Society.
Research Interests
• Drug therapy in children, medication compliance and the effects of drugs in pregnancy
Research Activities
Dr. Matsui’s research interests include drug therapy in children, medication compliance and the effects of drugs in pregnancy. She was awarded the K.M Piafsky Young Investigator Award of the Canadian Society for Clinical Pharmacology in 1998.
Representative Publications
- Jayaraman S, Rieder MJ, Matsui D (2005). Compliance Assessment in
Drug Trials: Has there been improvement in two decades? Can J Clin Pharmacol
e251-e253.
- Koren G, Matsui D, Einarson A, Knoppert D, Steiner M (2005). Is maternal use of selective sertonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates? CMAJ 172:1457-9
- Matsui D (2005). Adherence. In: Osborn, Dewitt, First, Zenel, eds.
Pediatrics, 1st edition. Philadelphia: Elsevier Mosby; p. 1782-4.
- Matsui D, Kwan C, Steer E, Rieder MJ (2003). The trials and tribulations
of doing drug research in children. CMAJ 169:1033-4.
- Koren G, Matsui D, Bailey B (2003). DEET-based insect repellents: safety
implications for children and pregnant and lactating women. CMAJ 169:209-12.
- Matsui D, Jardine M, Steer E, Cukernik V, Rieder MJ (2003). Where physicians
look for information on drug prescribing for children. Paediatr Child
Health 8:219-21.
- Matsui D, Joubert GIE, Dykxhoorn S, Rieder MJ (2000). Compliance with
Prescription Filling in the Pediatric Emergency Department. Arch Pediatr
Adolesc Med 154:195-8.
- Cho M, Matsui D, Rieder MJ (1998). Physicians' attire as perceived
by young children and their parents: The myth of the white coat syndrome.
Pediatr Emerg Care 14:198-201.
- Matsui D, Lim R, Tschen T, Rieder MJ (1997). Assessment of the Palatability
of ß-lactamase-Resistant Antibiotics in Children. Arch Pediatr Adolesc
Med 151:599-602.
- Matsui D (1997). Drug Compliance in Pediatrics: Clinical and Research Issues. Pediatr Clin North Am 44:1-14.
